Levy, M., Andorsky, D., Bremer, C., Zeidner, J., Palmisiano, N., McCune, S., Hunter, A., Nooruddin, Z., Abdulhaq, H., Oehler, V., Dakhil, S., Mulherin, B., Fonseca, G., Heinrich, M., Jamy, O., Koller, P., Sasaki, K., Sadek, I. M., Yang, D., Laine, D., Sabo, J. (., Hall, A., Gianchandani, D., Mauro, M., Cortés, J., Atallah, E. (2025). Asciminib (ASC) in chronic myeloid leukemia in chronic Phase (CML-CP): Interim analysis (IA) efficacy and safety results of the Phase 2 ASC2ESCALATE trial in the cohort of newly diagnosed (1L) patients (pts). Blood. https://doi.org/10.1182/blood-2025-3775